{
  "trial_id": "NCT03566667",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "follow-up visits, a reduced complexity at the visits, and an intervention that is additional to standard care but with no placebo control",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "patients managed at the Department of Respiratory Medicine at Orebro University Hospital or primary health care centers in Region Orebro County, with a doctor's diagnosis of COPD",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "no International Classification of Diseases (ICD) codes for cardiovascular diseases and no present beta-blocker therapy",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "atrioventricular (AV) block II or III without pacemaker, atrial fibrillation or flutter, clinical signs of or previously known cardiovascular disease",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "systolic blood pressure < 90, severe asthma, present beta-blocker therapy or ongoing COPD exacerbation",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has multifactorial chronic hypoxemia and dyspnea thought due to diastolic CHF, pulmonary hypertension thought secondary to a chronic ASD and COPD on 5L home oxygen. Patient refused right heart cath for evaluation of response to sildenafil but tolerated an inpatient trial without hypotension.",
  "_meta": {
    "topic_id": "16",
    "trial_id": "NCT03566667",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}